首页> 外国专利> COMPOSITION COMPRISING CAMELLIA JAPONICA L. EXTRACT AS EFFECTIVE COMPONENT FOR PREVENTING, TREATING, OR ALLEVIATING OCULAR FATIGUE, OCULAR INFLAMMATION, OR DRY EYE SYNDROME

COMPOSITION COMPRISING CAMELLIA JAPONICA L. EXTRACT AS EFFECTIVE COMPONENT FOR PREVENTING, TREATING, OR ALLEVIATING OCULAR FATIGUE, OCULAR INFLAMMATION, OR DRY EYE SYNDROME

机译:包含山茶花提取物的成分,作为预防,治疗或消除眼疲劳,眼炎症或干眼症的有效成分

摘要

The present invention relates to a composition comprising a Camellia japonica L. extract as an effective component for preventing, treating, or alleviating ocular fatigue, ocular inflammation, or dry eye syndrome. In an animal model of dry eye syndrome, the effective component of the present invention, a Camellia japonica L. extract is shown to promote tear secretion, prolong tear film breakup time, and delay damage to corneal epithelial cells, as well as to reduce the expression of inflammatory cytokinase on the ocular surface and in lacrimal glands, and suppress the migration of macrophages in response to inflammation, thereby preventing, treating, or alleviating ocular fatigue, ocular inflammation, or dry eye syndrome. Further, the Camellia japonica L. extract of the present invention has no cytotoxicity and side effects, and thus may be safely used in a pharmaceutical composition, quasi-drug composition, or food composition.;COPYRIGHT KIPO 2017
机译:本发明涉及包含山茶提取物作为预防,治疗或减轻眼疲劳,眼炎症或干眼症的有效成分的组合物。在干眼综合征的动物模型中,本发明的有效成分山茶提取物显示出促进泪液分泌,延长泪膜破裂时间,延迟对角膜上皮细胞的损害并减少了角膜上皮细胞的损伤。在眼表面和泪腺中表达炎症性细胞激酶,并抑制巨噬细胞对炎症的反应,从而预防,治疗或减轻眼疲劳,眼部炎症或干眼症。此外,本发明的山茶提取物没有细胞毒性和副作用,因此可以安全地用于药物组合物,准药物组合物或食品组合物中。; COPYRIGHT KIPO 2017

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号